April 23, 2008 (Barcelona) — Moxifloxacin (MXF) is well tolerated, is significantly more effective at reducing pain, and shows significantly improved clinical efficacy over clindamycin (CLI) in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback